EGFR and non-small cell lung carcinoma: It is reported that more than 80% EGFR mutations in NSCLC are deletions in exon 19 and a point mutation (L858R) in exon 21, which induces the constitutive activation of EGFR in the EGFR mutant cancer cells (6, 7).